BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 17980738)

  • 1. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
    Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
    Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His.
    Schweitzer K; Ehmann D; Garcia R; Alport E
    Can J Ophthalmol; 2009 Jun; 44(3):317-9. PubMed ID: 19491989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
    Solano JM; Pulido JS; Salomao DR
    Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
    Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
    Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis.
    Nakagawa K; Sheikh SI; Snuderl M; Frosch MP; Greenberg SM
    J Neurol Sci; 2008 Sep; 272(1-2):186-90. PubMed ID: 18579156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.
    Beirão NM; Matos E; Beirão I; Costa PP; Torres P
    Retina; 2011; 31(7):1373-7. PubMed ID: 21358362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostaining images of vitreous transthyretin amyloid.
    Latasiewicz M; Adan A; Solé M
    Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation.
    Mathieu F; Morgan E; So J; Munoz DG; Mason W; Kongkham P
    World Neurosurg; 2018 Mar; 111():190-193. PubMed ID: 29277593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular amyloidosis and secondary glaucoma.
    Nelson GA; Edward DP; Wilensky JT
    Ophthalmology; 1999 Jul; 106(7):1363-6. PubMed ID: 10406623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transthyretin Arg-83 mutation in vitreous amyloidosis].
    Chen L; Lü L; Zhang P; Li Y; Lin J
    Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
    Zou X; Dong F; Zhang S; Tian R; Sui R
    Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathologic spectrum of oculoleptomeningeal amyloidosis with Val30Gly transthyretin gene mutation in a postmortem case.
    Martin SE; Benson MD; Hattab EM
    Hum Pathol; 2014 May; 45(5):1105-8. PubMed ID: 24613567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His.
    Blevins G; Macaulay R; Harder S; Fladeland D; Yamashita T; Yazaki M; Hamidi Asl K; Benson MD; Donat JR
    Neurology; 2003 May; 60(10):1625-30. PubMed ID: 12771253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considering amyloidosis in patients with clinically unresponsive vitreous inflammation (Oculoleptomeningeal amyloidosis in 3 individuals with transthyretin variant Tyr69His. Vol. 44[3]).
    Roe RH; Cunningham ET
    Can J Ophthalmol; 2010 Feb; 45(1):81. PubMed ID: 20130721
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.
    Nakamura M; Yamashita T; Ueda M; Obayashi K; Sato T; Ikeda T; Washimi Y; Hirai T; Kuwahara Y; Yamamoto MT; Uchino M; Ando Y
    Neurology; 2005 Oct; 65(7):1051-6. PubMed ID: 16217058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy.
    Miyahara T; Ohta K; Yamamoto Y; Ueno A; Murata T
    J Glaucoma; 2007 Jan; 16(1):169-70. PubMed ID: 17224769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amyloidosis of the vitreous body. Possibilities of diagnosis].
    Soltau JB; Seiberth V; Knorz MC; Liesenhoff H
    Fortschr Ophthalmol; 1991; 88(4):408-10. PubMed ID: 1786932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
    Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
    J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation.
    Shimizu Y; Takeuchi M; Matsumura M; Tokuda T; Iwata M
    Amyloid; 2006 Mar; 13(1):37-41. PubMed ID: 16690499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.